Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 31, 2026

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

Biomarker development for musculoskeletal diseases.

Wan Huang1, Gwendolyn Sowa

  • 1Department of Physical Medicine and Rehabilitation, Ferguson Laboratory for Orthopaedic Research, University of Pittsburgh, Pittsburgh, PA, USA.

PM & R : the Journal of Injury, Function, and Rehabilitation
|June 28, 2011
PubMed
Summary

Biomarkers in body fluids can assess musculoskeletal (MSK) disease activity, complementing imaging. Multi-biomarker panels offer potential for improved diagnosis and treatment validation in MSK disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-Phase Multicenter Luminescent Lanthanide-Organic Frameworks for Ratiometric Detection of Nitrofurantoin.

Inorganic chemistry·2026
Same author

Amplified Assembly of a Multifunctional 3D DNA Nanomachine for Electrochemical and Colorimetric Dual-Mode Assays.

Analytical chemistry·2026
Same author

Larger Lumbar Vertebral Body Osteophyte Volume Is Associated With Older Age and a More Caudal Vertebral Level in Individuals With Chronic Low Back Pain.

JOR spine·2026
Same author

Impact of Menopause and Associated Hormonal Changes on Spine Health in Older Females: A Review.

Cells·2026
Same author

Gait dual-task cost in individuals with chronic low back pain and high avoidance or catastrophizing.

Gait & posture·2025
Same author

Associations Between Fear-Avoidance or Pain Catastrophizing and Gait Quality in Chronic Low Back Pain: A Cross-Sectional Study.

Physical therapy·2025

Area of Science:

  • Biochemistry
  • Immunology
  • Orthopedics

Background:

  • Musculoskeletal (MSK) disorders affect over 25% of Americans, with imaging often poorly correlating to disease activity, especially in older adults.
  • Current imaging techniques reveal structural changes but not the dynamic disease processes or symptom severity in MSK conditions.
  • The aging population presents unique challenges, often exhibiting multiple pain sources and a disconnect between imaging results and patient symptoms.

Purpose of the Study:

  • To review novel biomarkers for assessing MSK disease activity and treatment response in body fluids.
  • To explore the potential of multi-biomarker panels for diagnosis, prognosis, and treatment validation in MSK diseases.
  • To evaluate biomarkers that reflect disease activity beyond structural changes seen in imaging.

Main Methods:

More Related Videos

A Novel Application of Musculoskeletal Ultrasound Imaging
10:53

A Novel Application of Musculoskeletal Ultrasound Imaging

Published on: September 17, 2013

Related Experiment Videos

Last Updated: May 31, 2026

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

A Novel Application of Musculoskeletal Ultrasound Imaging
10:53

A Novel Application of Musculoskeletal Ultrasound Imaging

Published on: September 17, 2013

  • Review of MSK biomarkers categorized by mechanism: extracellular matrix metabolites, inflammatory cytokines/chemokines, and pain-related neuropeptides/chemicals.
  • Analysis of the potential of individual biomarkers versus panels for MSK disease assessment.
  • Consideration of biomarker integration with existing imaging tools.

Main Results:

  • Biomarkers, including inflammatory and matrix breakdown products, can indicate disease activity and active pain generators.
  • Multi-biomarker panels, encompassing various mechanisms, show greater potential than single biomarkers due to the multi-tissue nature of MSK diseases.
  • Biomarkers can provide crucial information on disease activity and treatment response, complementing imaging findings.

Conclusions:

  • Biomarker evaluation in body fluids offers a promising avenue for assessing MSK disease activity and symptom severity.
  • Multi-biomarker panels, potentially integrating different mechanistic categories, are likely to be more effective than single markers.
  • The combination of multi-biomarker panels with imaging tools could revolutionize the clinical management of musculoskeletal disorders.